Skip to main content
OpenTrials

Clinical trial condition

Pathologic Complete Response

Explore clinical trials studying Pathologic Complete Response. Study availability and eligibility vary by location and protocol.

98 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Pathologic Complete Response trial results

Active, not recruiting

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

NCT04229979

Conditions
Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
Locations
  • O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • UCLA Medical Hematology and Oncology Los Angeles, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Colorado Blood Cancer Institute - SCRI - PPDS Denver, Colorado, United States
View all 73 locations
View Trial Details
Active, not recruiting

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

NCT03522246

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +30 more
Locations
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Clinical Research Center Concord, California, United States
View all 238 locations
View Trial Details
Completed

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

NCT06996301

Conditions
Disease, Disease Attributes, Disease Progression, +15 more
Locations
  • Silicon Valley Medical Development San Jose, California, United States
  • Albany Urology Clinic & Surgery Center Albany, Georgia, United States
  • Augusta Urology Associates Evans, Georgia, United States
  • Colquitt Regional Medical Center Moultrie, Georgia, United States
View Trial Details
Completed

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

NCT01757535

Conditions
Disease Attributes, Disease Progression, Hematologic Diseases, +9 more
Locations
  • Arizona Oncology Associates, P.C. Phoenix, Arizona, United States
  • Providence St Joseph Medical Center Cancer Center Burbank, California, United States
  • City Of Hope Duarte, California, United States
  • University of California San Francisco Fresno Campus Fresno, California, United States
View all 223 locations
View Trial Details

Related conditions